Life Science

BH2 is a precursor of BH4 synthesis. It is a noncompetitive inhibitor of GTP cyclohydrolase I, with a Ki of 14.4 &microM.

BH2 is a precursor of BH4 synthesis. It is a noncompetitive inhibitor of GTP cyclohydrolase I, with a Ki of 14.4 &microM.

BH2 is a precursor of BH4 synthesis. It is a noncompetitive inhibitor of GTP cyclohydrolase I, with a Ki of 14.4 &microM.

An agonist of TrkB (Kd = 320 nM) that protects TrkB-expressing neurons from apoptosis neuroprotective in an animal model of Parkinson&rsquos disease, reverses memory deficits in a mouse model of Alzheimer&rsquos disease, and improves motor

An agonist of TrkB (Kd = 320 nM) that protects TrkB-expressing neurons from apoptosis neuroprotective in an animal model of Parkinson&rsquos disease, reverses memory deficits in a mouse model of Alzheimer&rsquos disease, and improves motor

An agonist of TrkB (Kd = 320 nM) that protects TrkB-expressing neurons from apoptosis neuroprotective in an animal model of Parkinson&rsquos disease, reverses memory deficits in a mouse model of Alzheimer&rsquos disease, and improves motor

An agonist of TrkB (Kd = 320 nM) that protects TrkB-expressing neurons from apoptosis neuroprotective in an animal model of Parkinson&rsquos disease, reverses memory deficits in a mouse model of Alzheimer&rsquos disease, and improves motor

A fluorescent DNA dye that is commonly used for the detection or exclusion of non-viable cells in flow cytometric analysis exhibits minimal spectral overlap with and can be used with PE and FITC can also be used to evaluate apoptosis and

A fluorescent DNA dye that is commonly used for the detection or exclusion of non-viable cells in flow cytometric analysis exhibits minimal spectral overlap with and can be used with PE and FITC can also be used to evaluate apoptosis and

7-Bromoisoquinoline is a synthetic intermediate useful for pharmaceutical synthesis.

7-Bromoisoquinoline is a synthetic intermediate useful for pharmaceutical synthesis.

7-Bromoisoquinoline is a synthetic intermediate useful for pharmaceutical synthesis.